Jessica R. Tait

Parkville, VIC 3052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Bioactive cationic lipidated oligomers (CLOs) as antimicrobial materials: metabolomic insights into MRSA membrane disruption.

Bioactive cationic lipidated oligomers (CLOs) as antimicrobial materials: metabolomic insights into MRSA membrane disruption.

Journal: Biomaterials science

Published: February 25, 2026

Dual β-lactam therapy against high-risk Pseudomonas aeruginosa isolates: a dynamic in-vitro infection model study integrating population genomics with quantitative systems pharmacology modelling and simulations.

Dual β-lactam therapy against high-risk Pseudomonas aeruginosa isolates: a dynamic in-vitro infection model study integrating population genomics with quantitative systems pharmacology modelling and simulations.

Journal: The Lancet. Microbe

Published: March 20, 2025

Cholesterol-terminated cationic lipidated oligomers (CLOs) as a new class of antifungals.

Cholesterol-terminated cationic lipidated oligomers (CLOs) as a new class of antifungals.

Journal: Journal of materials chemistry. B

Published: January 27, 2025

Effects of different resistance mechanisms on bacterial response to meropenem, ciprofloxacin, and their combination described by next-generation mechanism-based modelling.

Effects of different resistance mechanisms on bacterial response to meropenem, ciprofloxacin, and their combination described by next-generation mechanism-based modelling.

Journal: International journal of antimicrobial agents

Published: December 06, 2024

Multiomics informed mathematical model for meropenem and tobramycin against hypermutable Pseudomonas aeruginosa.

Multiomics informed mathematical model for meropenem and tobramycin against hypermutable Pseudomonas aeruginosa.

Journal: International journal of antimicrobial agents

Published: September 25, 2024

Providing insight into the mechanism of action of cationic lipidated oligomers using metabolomics.

Providing insight into the mechanism of action of cationic lipidated oligomers using metabolomics.

Journal: mSystems

Published: April 12, 2024

The effects of single and multiple resistance mechanisms on bacterial response to meropenem.

The effects of single and multiple resistance mechanisms on bacterial response to meropenem.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: March 01, 2024

Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa.

Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa.

Journal: Antimicrobial agents and chemotherapy

Published: February 20, 2024

Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.

Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.

Journal: International journal of antimicrobial agents

Published: January 19, 2024

Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.

Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.

Journal: Antimicrobial agents and chemotherapy

Published: July 10, 2023

Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease.

Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: March 14, 2023

Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.

Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.

Journal: Antimicrobial agents and chemotherapy

Published: January 18, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026